NL-OMON50688尚未招募4 期
Exploring the Pharmacomicrobiomics of Depression - Pharma-biome
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Aged >= 18
- •Main diagnosis of unipolar depression
- •Indication for the prescription of an antidepressant
- •Starting a new SSRI/SNRI or TCA antidepressant treatment
- •Having already used one or more antidepressants without effect and/or with
- •side-effects
排除标准
- •Use of antibiotics in a period of three months prior to the baseline visit
- •Currently pregnant or breastfeeding
研究者
相似试验
招募中
4 期
Exploring the Pharmacomicrobiomics of DepressionMajor Depressive Disorder2024-518101-18-02Radboud universitair medisch centrum Stichting25
招募中
不适用
Depression and Microbiota: Biological, and Psychological markers of treatment responsedepressionbiologische markersMajor depressive disorders10027946NL-OMON49635Academisch Medisch Centrum350
已完成
不适用
Microbiome of Depression & Treatment Response to CitalopramMajor Depressive Disorder, Bipolar I and Bipolar IINCT02330068Mayo Clinic34
已完成
不适用
Gut microbiota of patients with depression and anxiety disorders: A prospective observational studyDepressive disorders, anxiety disordersJPRN-UMIN000021833Keio University School of Medicine50
招募中
2 期
Effect of Probiotics "Psychobiotics" on Depression and Metabolic Syndrome in Saudi ArabiaDepression Anxiety DisorderNCT06765057Roaa Ahmed Alkreadees60